Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMOJEV vs CD.JEVAX in Healthy Toddlers
NCT01396512Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2011
- Primary completion
- Mar 2013
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Jul 2011; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01396512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396512.